compound 27 [PMID: 36449304]   Click here for help

GtoPdb Ligand ID: 12314

Synonyms: inhibitor T35
PDB Ligand
Compound class: Synthetic organic
Comment: This compound is a first-in-class inhibitor of the cytidine 5'-triphosphate synthetases, CTPS1 and -2 [1], that are key enzymes that mediate the final step in de novo cytidine biosynthesis. Rapidly proliferating cancer cells are sensitive to reduced availability of pyrimidines, so the development of small molecule inhibitors of critical steps in the de novo synthesis pathway are the focus of active drug development programmes. CTPS1-selective inhibitors are proposed for anti-inflammatory activity, as CTPS1 is the isoform that is predominantly responsible for CTP synthesis in activated lymphocytes. Compound 27 is potent, and orally bioavailable, and it provides a chemotype for non-nucleotide CTPS inhibitors for the design of agents with improved CTPS1-selectivity.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 163.45
Molecular weight 512.09
XLogP 2.2
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES O=C(C(c1csc(n1)NS(=O)(=O)C1CC1)(C)C)Nc1ccc(cn1)c1cncc(n1)C(F)(F)F
Isomeric SMILES CC(C)(C(=O)Nc1ccc(cn1)c1cncc(n1)C(F)(F)F)c1csc(n1)NS(=O)(=O)C1CC1
InChI InChI=1S/C20H19F3N6O3S2/c1-19(2,15-10-33-18(27-15)29-34(31,32)12-4-5-12)17(30)28-16-6-3-11(7-25-16)13-8-24-9-14(26-13)20(21,22)23/h3,6-10,12H,4-5H2,1-2H3,(H,27,29)(H,25,28,30)
InChI Key CZIDGRDZSFIUHX-UHFFFAOYSA-N
Bioactivity Comments
Inhibits CYP450 2C9 by 60% at 10 μM, and human ether-a-go-go-related gene (hERG) channels by 27% at 33 μM [1]. In vivo, compound 27 improved indicators of disease severity in a mouse collagen-induced arthritis (CIA) model, with efficacy similar to that of the approved JAK-targeting anti-inflammatory drug tofacitinib.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CTP synthase 2 Hs Inhibitor Inhibition 7.7 pIC50 - 1
⤷ pIC50 7.7 (IC50 1.8x10-8 M) [1]
CTP synthase 2 Rn Inhibitor Inhibition 7.6 pIC50 - 1
⤷ pIC50 7.6 (IC50 2.3x10-8 M) [1]
CTP synthase 1 Mm Inhibitor Inhibition 7.6 pIC50 - 1
⤷ pIC50 7.6 (IC50 2.6x10-8 M) [1]
CTP synthase 1 Rn Inhibitor Inhibition 7.6 pIC50 - 1
⤷ pIC50 7.6 (IC50 2.7x10-8 M) [1]
CTP synthase 1 Hs Inhibitor Inhibition 7.5 pIC50 - 1
⤷ pIC50 7.5 (IC50 3.2x10-8 M) [1]
CTP synthase 2 Mm Inhibitor Inhibition 7.5 pIC50 - 1
⤷ pIC50 7.5 (IC50 3.3x10-8 M) [1]